Chemistry Reference
In-Depth Information
102. Nakamura, S. et al., Suppressive effects of partially hydrolized guar gum on transitory
diarrhea induced by ingestion of maltitol and lactitol in healthy humans,
Eur. J. Clin.
Nutr.,
61, 1086, 2007.
103. Lanthier, P.L. and Morgan, M.Y., Lactitol in the treatment of chronic hepatic encephal-
opathy: An open comparison with lactulose,
Gut,
26, 415, 1985.
104. Mas, A. et al., Comparison of rifaximin and lactitol in the treatment of acute hepatic
encephalopathy: Results of a randomized, double-blind, double dummy, controlled clin-
ical trial,
J. Hepatol.
, 38, 51, 2003.
105. Camma, C. et al., Lactitol in the treatment of chronic hepatic encephalopathy. A meta-
analysis,
Dig. Dis. Sci
., 38, 916, 1993.
106. Als-Nielsen, B., Gluud, L.L., and Gluud, C., Nonabsorbable disaccharides for hepatic
encephalopathy,
Cochrane Database Syst. Rev
., 2, CD003044, 2004.
107. Ammann, P., Rizzoli, R., and Fleisch, H., Influence of the disaccharide lactitol on intes-
tinal absorption and body retention of calcium in rats,
J. Nutr.
, 118, 793, 1988.
108. Yanahira, S. et al., Effects of lactitol-oligosaccharides on calcium and magnesium
absorption in rats,
J. Nutr. Sci. Vitaminol.
, 43, 123, 1997.
109. Egger, B. et al., Effect of one month of lactitol treatment on calcium metabolism in man,
Eur. J. Pharmacol.
, 37, 205, 1989.
110. Shimomura, Y. et al., Attenuated response of the serum triglyceride concentration to
ingestion of a chocolate containing polydextrose and lactitol in place of sugar,
Biosci.
Biotechnol. Biochem.,
69, 1819, 2005.
111. Chen, C. et al., Effects of lactitol on intestinal microflora and plasma endotoxin in
patients with chronic viral hepatitis,
J. Infect.
, 54, 98, 2007.
112. Buscaglia, C.A. et al.,
Trypanasoma cruzi
surface mucins: Host-dependent coat diver-
sity,
Nat. Rev. Microbiol.
, 4, 229, 2006.
113. Augusti, R. et al., Lactose derivatives are inhibitors of
Trypanosoma cruzi
trans-sialidase
activity toward conventional substrates
in vitro
and
in vivo
,
Glycobiology
, 14, 659, 2004.
114. Grenby, T.H. and Phillips, A., Dental and metabolic effects of lactitol in the diet of labo-
ratory rats,
Br. J. Nutr
., 61, 17, 1989.
115. Grenby, T.H., Latest state of research on lactitol and dental carries,
Int. Dent. J
., 39, 25,
1989.
116. van Loveren, C., Sugar alcohols: What is the evidence for caries-preventive and caries-
therapeutic effects?
Caries Res.,
38, 286, 2004.
117. Park, J.Y. et al., A case of recurrent pneumatosis cystoides intestinalis associated with
recurrent pneumoperitoneum [English abstract only],
Korean J. Gastroenterol
., 50, 188,
2007.
118. Prentice, D.E. and Meikle, A.W., A review of drug-induced Leydig cell hyperplasia and
neoplasia in the rat and some comparison with man,
Hum. Exp. Toxicol.
, 14, 562, 1995.
119. Vernia, P. et al., Topical butyrate improves efficacy of 5-ASA in refractory distal ulcer-
ative colitis: Results of a multicentre trial,
Eur. J. Clin. Invest.
, 33, 244, 2003.
120. Hallert, C. et al., Increasing fecal butyrate in ulcerative colitis patients by diet: Controlled
pilot study,
Inflamm. Bowel Dis.
, 9, 116, 2003.
121. Lupton, J.R., Microbial degradation products influence colon cancer risk: The butyrate
controversy,
J. Nutr.,
134, 479, 2004.
122. Holt, P.R., Dairy foods and prevention of colon cancer: Human studies,
J. Am. Coll.
Nutr.,
18, 379S, 1999.
123. Norat, T. and Riboli, E., Dairy products and colorectal cancer. A review of possible
mechanisms and epidemiological evidence,
Eur. J. Clin. Nutr.,
57, 1, 2003.
